Feasibility and acceptability of an anti-fouling silicone urinary catheter for long-term catheterisation: a single-centre, single-blind randomised pilot and feasibility study
This single-centre, single-blind randomised pilot study demonstrates that an anti-fouling silicone urinary catheter with a blended zwitterionic polymer is feasible, safe, and highly acceptable for long-term use in frail elderly patients, thereby supporting the design of a larger confirmatory trial while generating hypothesis-generating signals regarding reduced ketone positivity and divergent bacterial trajectories.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people around the world, a thin plastic tube is the only way their bodies can empty a bladder. These indwelling urinary catheters are a lifeline for those who cannot control their own flow, but they come with a heavy price. Once inserted, the tube becomes a highway for bacteria, which quickly form a slimy, protective layer called a biofilm on the surface. This layer acts like a shield, hiding the germs from the body's defenses and making them nearly impossible to wash away with standard medicine. As the biofilm grows, it traps minerals from the urine, turning the soft plastic hard and crusty, which can block the tube and cause painful, difficult removals. For decades, scientists have tried to solve this by coating the tubes with silver or other antimicrobial substances, but these coatings often wear off or fail to stop the infection completely. The search has turned toward a different idea: instead of trying to kill the bacteria with poison, what if the tube surface itself was so slippery and water-loving that the bacteria simply could not stick to it in the first place?
A team of researchers at National Cheng Kung University Hospital in Taiwan recently put this idea to the test in a small, careful study involving forty elderly patients who needed long-term catheter care. They tested a new type of catheter made from silicone that had a special, water-binding polymer mixed directly into the material itself, rather than just painted on the outside. This design meant the anti-stick properties were built into the wall of the tube, so they would not peel off or wear away over time. The study was not designed to prove that this new tube was a miracle cure, but rather to see if such a device could be safely used in a real-world setting, if patients could tolerate the strict schedule of having it changed every month, and if the researchers could successfully collect the necessary data to plan a much larger study in the future.
The results showed that the plan was entirely workable. The researchers successfully recruited the participants, and every single one of them stayed in the study long enough to complete at least one monthly catheter change, with most staying for five or more cycles. This was a significant achievement, as the patients were frail and elderly, and the process of changing a catheter can be uncomfortable and logistically difficult for families and caregivers. No serious problems occurred with the new device itself; there were no injuries or unexpected medical issues caused by the tube. The patients and their families found the monthly routine acceptable, and many were even willing to continue using the system after the study ended, sometimes paying for it themselves. This high level of cooperation suggests that a larger, more definitive trial is possible and that patients are willing to engage with this kind of long-term care model.
When the researchers looked at the medical data, they found that the new catheter did not cause any harm, but they also could not yet say for certain that it was better at preventing infections than the standard tubes. In this small group, the rate of urinary tract infections was low in both groups, and because almost all long-term catheter users develop bacteria in their urine eventually, it was hard to tell the difference between the two types of tubes based on infection counts alone. However, the study did uncover some interesting clues that might guide future research. The patients using the new anti-fouling catheter showed lower levels of ketones in their urine, a chemical marker that often rises when the body is under stress or not getting enough food. While the researchers could not prove this was a direct result of the catheter, it is a hint that the new tube might reduce the physical stress or discomfort associated with the device, which in turn could lower the body's stress response.
Another curious finding involved the microscopic behavior of bacteria over time. While the overall number of bacteria did not change drastically, the pattern of how they appeared in the urine samples shifted differently for the two groups. In the group with the new catheter, the signs of bacteria seemed to rise slightly over the months, whereas in the group with the standard catheter, they seemed to drop. The researchers are very careful to note that this does not mean the new tube is dangerous or causes more infection; rather, it is a strange signal that needs to be understood better. It is possible that the new surface changes how bacteria settle or how they are washed away in a way that looks different under a microscope but does not necessarily lead to sickness.
Ultimately, this study serves as a successful proof of concept. It demonstrated that a catheter with a built-in, non-stick surface can be manufactured, distributed, and used safely by frail, elderly patients in their homes and hospitals. The high retention rate and the willingness of families to continue the monthly changes provide a strong foundation for a larger, multi-center trial. The researchers now have the safety data and the estimates of how the device behaves over time to design a bigger study that can definitively answer whether this new material can truly reduce the burden of infection and discomfort for those who rely on these tubes every day. The work confirms that the path forward is open, but the journey to a proven solution requires more miles to be traveled.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.